We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$21.5B
AUM Growth
+$1.77B
Cap. Flow
+$1.09B
Cap. Flow %
5.05%
Top 10 Hldgs %
53.56%
Holding
4,787
New
28
Increased
1,004
Reduced
647
Closed
2,866

Sector Composition

Rank Sector Weight
1 Financials 5.08%
2 Technology 4.32%
3 Energy 3.31%
4 Communication Services 2.33%
5 Healthcare 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFG icon
1776
Mizuho Financial
MFG
$120B
$41K ﹤0.01%
11,436
-2,285
-17% -$8.03K
TGB
1777
Trekor Metals
TGB
$2.45B
$41K ﹤0.01%
21,900
+500
+2% +$820
CGEN icon
1778
Compugen
CGEN
$212M
$39K ﹤0.01%
10,192
-200
-2% -$694
CRIS icon
1779
Curis
CRIS
$9.71M
$39K ﹤0.01%
13
-1
-7% -$3.7K
VIRX
1780
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$39K ﹤0.01%
571
+142
+33% +$11.6K
LEE icon
1781
Lee Enterprises
LEE
$175M
$37K ﹤0.01%
+1,683
New +$33.8K
OHAI
1782
DELISTED
OHA Investment Corporation
OHAI
$37K ﹤0.01%
29,250
BPTH
1783
DELISTED
Bio-Path Holdings Inc
BPTH
$36K ﹤0.01%
25
AUY
1784
DELISTED
Yamana Gold, Inc.
AUY
$36K ﹤0.01%
13,673
-31,965
-70% -$85.1K
AT
1785
DELISTED
Atlantic Power Corporation
AT
$36K ﹤0.01%
14,805
+810
+6% +$1.95K
AEMD icon
1786
Aethlon Medical
AEMD
$1.4M
$35K ﹤0.01%
2
VNRX icon
1787
VolitionRx Ltd
VNRX
$9.31M
$35K ﹤0.01%
660
ASXC
1788
DELISTED
Asensus Surgical, Inc.
ASXC
$34K ﹤0.01%
1,826
+556
+44% +$6.47K
IMI
1789
DELISTED
Intermolecular, Inc.
IMI
$34K ﹤0.01%
33,000
DHY
1790
Credit Suisse High Yield Credit Fund
DHY
$240M
$33K ﹤0.01%
11,601
AIXC
1791
AIxCrypto Holdings Inc
AIXC
$13.2M
$33K ﹤0.01%
1
RCG
1792
RENN Fund
RCG
$20.7M
$33K ﹤0.01%
23,806
-5,000
-17% -$6.72K
XCO
1793
DELISTED
Exco Resources
XCO
$33K ﹤0.01%
24,744
+900
+4% +$1.52K
GROW icon
1794
US Global Investors
GROW
$36.3M
$32K ﹤0.01%
14,875
PSV
1795
DELISTED
Hermitage Offshore Services Ltd.
PSV
$31K ﹤0.01%
2,183
+39
+2% +$500
PSTV icon
1796
Plus Therapeutics
PSTV
$25M
0
VERU icon
1797
Veru
VERU
$35.5M
$29K ﹤0.01%
1,102
CERS icon
1798
Cerus
CERS
$575M
$28K ﹤0.01%
10,121
AXU
1799
DELISTED
Alexco Resource Corp
AXU
$28K ﹤0.01%
19,600
CPRX
1800
DELISTED
Catalyst Pharmaceutical
CPRX
$27K ﹤0.01%
10,681

Similar funds

Creative Planning's Q3 2017 Portfolio in Review

As of Q3 2017, Creative Planning held 4,787 positions worth $21.5B, up 9% from $19.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Creative Planning deployed $1.09B of net new capital in Q3 2017, opening 28 new positions and adding to 1,004 existing holdings. Its largest new stake was Global X MSCI China Consumer Discretionary ETF: 53,331 shares worth $916K.

By sector, the portfolio is most concentrated in Financials at 5.1% of assets, down from 5.1% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $80.5M trimmed.

  • Creative Planning's largest Q3 2017 buy was Global X MSCI China Consumer Discretionary ETF: 53,331 shares worth $916K.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $139M increase.
  • Creative Planning's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $80.5M.
  • Creative Planning fully exited Oneok Partners LP in Q3 2017, selling an estimated $49.5M.
  • Creative Planning's ten largest holdings make up 54% of its $21.5B portfolio in Q3 2017.
  • Creative Planning opened 28 new positions and closed 2,866 in Q3 2017.
  • Creative Planning's portfolio value rose 9% quarter-over-quarter to $21.5B.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.